After taking a look at private payer activity in value-based care (VBC) last month, let’s now shift our attention to how community oncology providers are engaging in VBC. VBC encompasses a broad range of programs, which often confuses or conflates estimated level of participation (see more details in our VBC Special Report). For example, Medicare’s MIPS program includes most MDs and qualifies as VBC by some definitions, as it requires reporting and tracks some performance metrics.
To get a better sense of provider participation, we queried 5 main categories of VBC programs: OCM, ACOs, payer-sponsored pathways, payer-sponsored episode-of-care pilots, and capitation programs (Medicare or commercial payer). Here’s how community practices’ interest and participation in VBC appears now:
Lastly, we found that VBC participation may provide a source of additional revenue for community practices. Financial enhancements included service fees for oncology care coordination, and leveraging tools and connections obtained from oncology networks like USON to generate additional revenue from OCM and commercial payer initiatives. We look forward to closely following these VBC trends in community oncology in the future.
As always, please reach out with any comments or questions you have.
All the best...
-- HMP Market Access Insights Team
Welcome to the August 2023 edition of our Monthly Insight Series. This month we take a deeper look into independent community oncology practices’ evolving interest in joining oncology network aggregators.
Taylor CrutisonCMMI has launched its new oncology pilot, the Enhancing Oncology Model, sparking questions about its new features vs the Oncology Care Model, the benefits and concerns for participating practices, and CMMI’s ability to successfully implement the program.
Taylor CrutisonWelcome to the July 2023 edition of our Monthly Insights Series. This month we want to share some more thoughts on opportunities for manufacturer engagement with IDN stakeholders—the IDN pharmacy/pharmacists, in particular.
Cindy Chen